| 中文名 | 依法曲普 |
|---|---|
| 英文名 | Evifacotrep |
| 英文别名 |
Evifacotr
5-chloro-4-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1H-pyridazin-6-one 5-chloro-4-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1H-p 3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl] 4-chloro-5-{4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5H,6H,7H,8H-pyrido[3,4-d]pyrimidin-7-yl}-2,3-dihydropyridazin-3-one Evifacotr, 10 mM in DMSO Evifacotr,inhibit,Inhibitor,TRP Channel,Transient rector potential channels |
| 描述 | 依法曲普是一种短暂的受体电位通道5(TRPC5)拮抗剂(WO2020061162,化合物100),可用于神经疾病的研究[1]。 |
|---|---|
| 相关类别 | |
| 靶点 |
TRPC5[1] |
| 体外研究 | 依法曲普是一种短暂的受体电位通道5(TRPC5)拮抗剂[1]。 |
| 参考文献 |
[1]. WO2020061162 |
| 分子式 | C18H12ClF4N5O2 |
|---|---|
| 分子量 | 441.77 |